Motivated is a reliable telehealth platform that provides fast, safe, and effective ED treatment options while also giving ...

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.

The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...

BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the ...

The FDA authorizes compounding of certain drugs during shortages. Hims & Hers as well as other telehealth weight loss companies said at HLTH that compounded GLP-1 drugs aren't going away any time ...